HK1007500A1 - Liposomal formulations with a high antieoplastic agent/lipid ratio - Google Patents

Liposomal formulations with a high antieoplastic agent/lipid ratio

Info

Publication number
HK1007500A1
HK1007500A1 HK98106751A HK98106751A HK1007500A1 HK 1007500 A1 HK1007500 A1 HK 1007500A1 HK 98106751 A HK98106751 A HK 98106751A HK 98106751 A HK98106751 A HK 98106751A HK 1007500 A1 HK1007500 A1 HK 1007500A1
Authority
HK
Hong Kong
Prior art keywords
drug
liposomes
lipid ratio
antieoplastic
agent
Prior art date
Application number
HK98106751A
Other languages
English (en)
Inventor
Marcel B Bally
Richard S Ginsberg
George N Mitlenes
Pieter R Culis
Lawrence D Mayer
Original Assignee
Liposome Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21808094&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1007500(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Company filed Critical Liposome Company
Publication of HK1007500A1 publication Critical patent/HK1007500A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
HK98106751A 1987-03-05 1998-06-25 Liposomal formulations with a high antieoplastic agent/lipid ratio HK1007500A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2215487A 1987-03-05 1987-03-05

Publications (1)

Publication Number Publication Date
HK1007500A1 true HK1007500A1 (en) 1999-04-16

Family

ID=21808094

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106751A HK1007500A1 (en) 1987-03-05 1998-06-25 Liposomal formulations with a high antieoplastic agent/lipid ratio

Country Status (17)

Country Link
EP (2) EP0719546B1 (ko)
JP (1) JP2882607B2 (ko)
KR (1) KR960013703B1 (ko)
AT (2) ATE137670T1 (ko)
AU (3) AU620545B2 (ko)
BR (1) BR1100687A (ko)
CA (1) CA1338702C (ko)
DE (3) DE10199004I1 (ko)
DK (1) DK174869B1 (ko)
ES (2) ES2088385T3 (ko)
GR (1) GR3020725T3 (ko)
HK (1) HK1007500A1 (ko)
IE (1) IE75713B1 (ko)
IL (1) IL85608A (ko)
LU (1) LU90717I2 (ko)
NL (1) NL300036I1 (ko)
WO (1) WO1988006442A1 (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
CA1323306C (en) * 1987-03-05 1993-10-19 Mircea C. Popescu Pharmacological agent-lipid solution preparation
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
IE63518B1 (en) * 1987-11-18 1995-05-03 Vestar Inc Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
EP0472639A4 (en) * 1989-05-15 1992-07-01 The Liposome Company, Inc. Accumulation of drugs into liposomes by a proton gradient
US5227170A (en) * 1989-06-22 1993-07-13 Vestar, Inc. Encapsulation process
EP0412507A1 (de) * 1989-08-08 1991-02-13 Humboldt-Universität zu Berlin Verfahren zur Grössenfraktionierung hochmolekularer Stoffe mit Hilfe von Hohlträgern
ATE138803T1 (de) * 1990-07-31 1996-06-15 Liposome Co Inc Anhäufung von aminosäuren und peptiden in liposomen
JPH06505701A (ja) * 1990-09-10 1994-06-30 スクール・オブ・フアーマシー・ユニバーシテイ・オブ・ロンドン リポソーム
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
EP0661044A1 (en) * 1991-07-03 1995-07-05 NeXstar Pharmaceuticals, Inc. Drug-containing liposomes
EP0546951A1 (en) * 1991-12-13 1993-06-16 The Liposome Company, Inc. Combination of liposome encapsulated antineoplastic agents, such as doxorubicin with colony stimulating factors
US5741516A (en) * 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
DE4430592A1 (de) 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
US5858397A (en) * 1995-10-11 1999-01-12 University Of British Columbia Liposomal formulations of mitoxantrone
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
NZ514133A (en) * 1996-10-15 2001-09-28 Liposome Co Inc N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO1999065481A1 (en) * 1998-06-18 1999-12-23 Karolinska Innovations Ab Liposomal formulations of busulphan
US7351427B2 (en) 1998-06-18 2008-04-01 Busulipo Ab Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof
JP2003513030A (ja) * 1999-11-05 2003-04-08 シード・キャピタル・インヴェストメンツ−２・（エスシーアイ−２）・ベスローテン・フエンノートシャップ 低い水溶性および脂肪親和性を示す物質のカプセル化方法、およびこの方法により得られる製剤
US20030124180A1 (en) * 2000-05-02 2003-07-03 Jurgen Ebert Liposomes containing active substances
DK1389089T3 (da) * 2001-03-27 2009-12-21 Phares Pharm Res Nv Fremgangsmådeog sammensætning til solubilisering af en biologisk aktiv forbindelse med lav vandoplöselighed
EP1429726A2 (en) * 2001-09-06 2004-06-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparing liposome formulations with a predefined release profile
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
EP1565165A2 (en) * 2002-11-26 2005-08-24 Gilead Sciences, Inc. Liposomal formulations
NZ540778A (en) * 2002-12-31 2008-04-30 Zydus Bsv Res And Dev Private Non-pegylated long-circulating liposomes
WO2005072776A2 (en) * 2004-01-30 2005-08-11 Instytut Farmaceutyczny Liposomal formulations of the antineoplastic agents
WO2005092388A1 (ja) * 2004-03-26 2005-10-06 Terumo Kabushiki Kaisha リポソーム製剤
US20060051406A1 (en) * 2004-07-23 2006-03-09 Manjeet Parmar Formulation of insoluble small molecule therapeutics in lipid-based carriers
CN100566810C (zh) 2005-01-18 2009-12-09 国立大学法人北海道大学 用脂质膜被覆粒子的方法
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
JP2009518443A (ja) 2005-12-06 2009-05-07 リゲル ファーマシューティカルズ インコーポレーティッド 脂質を主材料とする担体に内封された、不溶性小分子治療剤の製剤
WO2010034837A1 (en) * 2008-09-26 2010-04-01 Phares Pharmaceutical Research N.V. Method of solubilising biologically active compounds
CN101474155B (zh) * 2009-01-24 2011-03-16 重庆医科大学 注射用肺靶向载药前体脂质体及其使用方法
PL387296A1 (pl) * 2009-02-17 2010-08-30 Instytut Farmaceutyczny Sposób aktywnego zamykania amfifilowych substancji czynnych w strukturach liposomowych
JP2012529502A (ja) * 2009-06-08 2012-11-22 エピターゲット・アーエス 非ラメラ形成ホスファチジルコリンを含む音響感受性薬物送達粒子
PL226015B1 (pl) 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
JP2015530387A (ja) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー 脂質複合体化シスプラチンによる肺癌の再発防止
US9801874B2 (en) 2012-11-20 2017-10-31 Spectrum Pharmaceuticals Method for the preparation of liposome encapsulated vincristine for therapeutic use
TWI678213B (zh) 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
KR20190122676A (ko) 2017-01-18 2019-10-30 테마섹 라이프 사이언스 래보러토리 리미티드 유사분열기세포의 표적화를 증가시키는 고안정화된 리포좀
GR20180100082A (el) * 2018-02-28 2019-09-25 ΝΙΚΟΛΑΟΣ Α. ΦΙΚΙΩΡΗΣ ΚΑΙ ΣΙΑ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΗΝΗΣ με δ.τ. IN TOUCH HEALTH Ε.Π.Ε Μεθοδος για την παραγωγη οχηματων μεταφορας λιπιδιων
WO2021076630A1 (en) * 2019-10-14 2021-04-22 The Regents Of The University Of California Nano-enabled immunotherapy in cancer
CN112023059B (zh) * 2020-06-03 2023-03-24 太原师范学院 一种pH响应型阿霉素无载体纳米药物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
US4551288A (en) * 1982-08-16 1985-11-05 Sandoz, Inc. Processes for the preparation of liposome drug delivery systems
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
CA1264668C (en) * 1984-06-20 1990-01-23 EXTRUSION TECHNIQUES FOR THE PRODUCTION OF LIPOSOMES
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4622188A (en) * 1984-12-21 1986-11-11 E. I. Du Pont De Nemours And Company Method for manufacturing liposomes
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents

Also Published As

Publication number Publication date
IE75713B1 (en) 1997-09-24
CA1338702C (en) 1996-11-12
DK98189D0 (da) 1989-03-01
EP0290296A3 (en) 1989-06-28
DE10199004I1 (de) 2001-03-29
IE960340L (en) 1988-09-05
IL85608A (en) 1992-07-15
ES2088385T3 (es) 1996-08-16
DK98189A (da) 1989-03-01
JPH02502458A (ja) 1990-08-09
JP2882607B2 (ja) 1999-04-12
IE880599L (en) 1988-09-05
LU90717I2 (fr) 2001-03-15
DE3856550T2 (de) 2003-12-11
AU645332B2 (en) 1994-01-13
IL85608A0 (en) 1988-08-31
EP0290296B1 (en) 1996-05-08
DE3855265D1 (de) 1996-06-13
KR890700340A (ko) 1989-04-24
BR1100687A (pt) 2000-02-08
AU635435B2 (en) 1993-03-18
KR960013703B1 (ko) 1996-10-10
ES2198429T3 (es) 2004-02-01
NL300036I1 (nl) 2001-03-01
GR3020725T3 (en) 1996-11-30
AU8141891A (en) 1991-10-10
AU1481688A (en) 1988-09-26
EP0719546A1 (en) 1996-07-03
WO1988006442A1 (en) 1988-09-07
EP0719546B1 (en) 2003-01-22
AU620545B2 (en) 1992-02-20
ATE137670T1 (de) 1996-05-15
DE3856550D1 (de) 2003-02-27
EP0290296A2 (en) 1988-11-09
ATE231389T1 (de) 2003-02-15
DE3855265T2 (de) 1996-12-12
DK174869B1 (da) 2004-01-12
AU8141791A (en) 1991-11-07

Similar Documents

Publication Publication Date Title
EP0290296A3 (en) Liposomal formulations with a high antineoplastic agent/lipid ratio
HUT52943A (en) Process for producing liposome compositions
AU587232B2 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
NO873492D0 (no) Fremgangsmaate for fremstilling av antifungale preparater.
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
FI895554A0 (fi) Menetelmä liposomaalisen prostaglandiinivalmisteen valmistamiseksi
CA2233961A1 (en) Stimulation of hair follicles
IL140892A (en) Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
DK0560138T3 (da) Liposomale præparater af virksomt stof og fremgangsmåde til deres fremstilling
EP0198765A3 (en) Preparation of liposomes

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080303